Atlas Trials

Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study

Clinical trial NCT05281770 · UNKNOWN

Trial details

NCT number
NCT05281770
Sponsor
Austrian Migraine Registry Collaboration
Status
UNKNOWN
Study type
OBSERVATIONAL
MigraineMigraine With AuraMigraine Without AuraChronic MigraineEpisodic Migraine
Start date
2022-10-01
Primary completion
2025-09-01
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.